Free press releases distribution network?

Agency / Source: Report Buyer Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Vaccines will Drive India's Biopharma Market to $5.7bn by 2013 Says New Report - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report providing an overview of the biggest sector of the Indian biotechnology market, biopharma
Vaccines will Drive India's Biopharma Market to $5.7bn by 2013 Says New Report

 

PRZOOM - /newswire/ - London, United Kingdom, 2008/09/15 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report providing an overview of the biggest sector of the Indian biotechnology market, biopharma.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The report “Booming Biotech Market in India” shows that biopharma made up for around 70% of the cumulative revenue in fiscal 2008 and registered INR 75.9 Billion (US$ 1.93 Billion) in revenue. Gaining strength from the ongoing research & development (R&D), the biopharma sector will exceed INR 224 Billion (US$ 5.7 Billion) by fiscal 2013.

According to the study, the total biopharma industry - consisting of therapeutics, vaccines, diagnostics, and other products such as statins - recorded a massive 26.9% growth in fiscal 2007 and continues to be the largest contributor to the overall biotech market in India.

The impressive performance of the Indian biopharma sector is the result of the strongly growing vaccine business, which accounted for about 50% of the total biopharma business in fiscal 2007. The vaccine business will remain dynamic in future, taking the overall biopharma market up. In addition to this, driven by a rise in chronic diseases and investments in the healthcare infrastructure, diagnostics and therapeutics business is also anticipated to have a bright future. The biopharma sector will further benefit from the fact that India is forecast to become a key biogenerics supplier to the developed world in near future.

The report is an exhaustive study of the thriving biotech market in the emerging economy, India. It provides prudent research and analysis supported by statistical facts and figures on parameters that make up the structure of the Indian biotech market. It describes the market landscape and gives comprehensive information on market size, structure, key segments, domestic consumption, exports, investment, and market share of key players.

“Booming Biotech Market in India” is available from Report Buyer. For more information, see website.

Report Buyer product ID: RCS00434

About Report Buyer
Report Buyer (reportbuyer.com) is a UK-based independent online store supplying business information. The website now carries over 85,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Report Buyer Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Vaccines will Drive India's Biopharma Market to $5.7bn by 2013 Says New Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Jonna Dagliden 
+44 (0) 20 7060 7474 press[.]reportbuyer.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Report Buyer Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today